Thyrotoxic Periodic Paralysis as a Presentation of Thyrotoxicosis: A Case Report

Naresh Kumar, Sanjay Pandit, Pratap Singh

Abstract


Thyrotoxic periodic paralysis (TPP) is a rare but potentially serious complication of hyperthyroidism characterized by muscular weakness and hypokalemia in a patient with thyrotoxicosis. It is predominantly seen in Asian males.The etiology of thyrotoxicosis in most of the cases of TPP is Graves’ disease. We present a case of a 19-year-old male who presented in emergency with paraparesis. Investigations revealed hypokalemia and thyrotoxicosis related to toxic nodular goitre. Diagnosis of thyrotoxic periodic paralysis was made and patient was treated with potassium replacement, propranolol and antithyroid treatment.


Full Text:

PDF

References


Kantola IM, TarssanenLT. Diagnosis of familial hypokalemic periodic paralysis: Role of potassium exercise test. Neurology 1992; 42: 2158-62. 2. Arya SN. Periodic paralysis. JIACAM 2002; 3(4): 37482. 3. Silva MR, Chiamolera MI, Kasamatsu TS et al. Thyrotoxic hypokalemic periodic paralysis, an endocrine emergency: Clinical and genetic features in 25 patients. Arq Bras Endocrinol Metabol 2004; 48: 196-215. 4. Neki NS. Hyperthyroid hypokalemic periodic paralysis. Pak J Med Sci 2016; 32(4): 1051-52. 5. Lin SH. Thyrotoxic periodic paralysis. Mayo Clin Proc 2005; 80: 99-105. 6. Ober KP. Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature. Medicine (Baltimore) 1992; 71: 109-20. 7. McFadzean AJ, Yeung R. Periodic paralysis complicating thyrotoxicosis in Chinese. BMJ 1967; 1(538): 451-55. 8. Maurya PK, Kalita J, Misra UK. Spectrum of hypokalemic periodic paralysis in a tertiary care centre in India. Postgrad Med J 2010; 86: 692‑95. 9. Papadopoulus KI, Diep T, Cleland B et al. Thyrotoxic periodic paralysis: Report of three cases and review of literature. J Intern Med 1997; 241:521-24. 10. Ambika Amblee A, Gulati S. Thyrotoxic Periodic Paralysis: Eight Cases in Males of Hispanic Origin from a Single Hospital. AACE Clinical Case Reports 2016; 2(1): e58-e64. 11. Gennari FJ. Hypokalemia. N Engl J Med 1998; 339(7): 451-58. 12. Chan A, Shinde R, Chow CC et al. In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. BMJ. 1991; 303(6810): 1096-99. 13. Ginsberg AM, Clutter WE, Shah SD et al. Triiodothyronine-induced thyrotoxicosis increases mononuclear leukocyte beta-adrenergic receptor density in man. J Clin Invest 1981; 67(6): 1785-91. 14. Wu CC, Chau T, Chang CJ et al. An unrecognized cause of paralysis in ED: Thyrotoxic normokalemic periodic paralysis. Am J Emerg Med 2003; 21: 71-73. 15. Valizadeh N, Zarrin S. A 32-year-old man with normokalemic thyrotoxic periodic paralysis. Malays J Med Sci 2013; 20: 81-83.

J. Adv. Res. Med. 2016; 3(2&3) Kumar N et al.

ISSN: 2349-7181

Maciel RM, Lindsey SC, Dias da Silva MR. Novel etiopathophysiological aspects of thyrotoxic periodic paralysis. Nat Rev Endocrinol 2011; 7: 657-67. 17. Ryan, DP, da Silva MR, Soong DW et al. Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell 2010; 140: 88-98. 18. Mellgren G, Bleskestad HI, Aanderud S et al. Thyrotoxicosis and paraparesis in a young woman: Case report and review of the literature. Thyroid 2002; 12: 77-80. 19. Ee B, Cheah JS. Electrocardiographic changes in

thyrotoxic periodic paralysis. J Elecrocardiol 1979; 12(3): 263-79. 20. Lin SH, Lin YF. Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. Am J Kidney Dis 2001; 37: 620‑23. 21. Kung AW. Clinical review: Thyrotoxic periodic paralysis: A diagnostic challenge. J Clin Endocrinol Metab 2006; 91: 2490‑95.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Journal of Advanced Research in Medicine